. | Reference Values . | Patient 1A . | Patient 1B . | Patient 3A . | Patient 3B . | Patient 4Ea . |
---|---|---|---|---|---|---|
Glucose, mg/dL (nmol/L) | 70–99 (3.9–5.5) | 173 (9.6) | 112 (6.2) | 85 (4.7) | 103 (5.7) | 124 (6.9) |
HbA1c, % | 4.1–6.0 | 9.5 | 6.5 | — | 5.9 | 8.4 |
Insulin, μU/mL | 2.6–24.9 | — | 51.6 | — | 13.6 | 21.1 |
Total cholesterol, mg/dL (mmol/L) | <190 (<4.9) | 192 (5.0) | 177 (4.6) | 162 (4.2) | 206 (5.3) | 234 (6.1) |
Triglycerides, mg/dL (mmol/L) | <150 (<1.7) | 638 (7.2) | 130 (1.5) | 62 (0.7) | 77 (0.9) | 93 (1.0) |
LDL, mg/dL (mmol/L) | <130 (<3.4) | — | 111 (2.9) | 86 (2.2) | 106 (2.7) | 170 (4.4) |
HDL, mg/dL (mmol/L) | >40 (>1.0) | 31 (0.8) | 41 (1.1) | 64 (1.7) | 83 (2.2) | 43 (1.1) |
FSH, IU/L | 3.5–12.5 | |||||
25.8–134.8c | 5.9 | 7.1 | 7.7 | 65.5 | 51.5 | |
LH, IU/L | 2.4–12.6 | 3.9 | 39.3 | 8.1 | 28.7 | 22.5 |
Testosterone, ng/dL (nmol/L) | 20–49 y: ≤48 (1.7) >50 y: ≤41 (1.4) | 32 (1.1)b | 101 (3.5) | 24 (0.8) | — | 46 (1.6) |
Androstenedione, ng/mL (nmol/L) | <2.2 (7.7) | — | 3.4 (11.9) | — | — | 0.75 (2.6) |
. | Reference Values . | Patient 1A . | Patient 1B . | Patient 3A . | Patient 3B . | Patient 4Ea . |
---|---|---|---|---|---|---|
Glucose, mg/dL (nmol/L) | 70–99 (3.9–5.5) | 173 (9.6) | 112 (6.2) | 85 (4.7) | 103 (5.7) | 124 (6.9) |
HbA1c, % | 4.1–6.0 | 9.5 | 6.5 | — | 5.9 | 8.4 |
Insulin, μU/mL | 2.6–24.9 | — | 51.6 | — | 13.6 | 21.1 |
Total cholesterol, mg/dL (mmol/L) | <190 (<4.9) | 192 (5.0) | 177 (4.6) | 162 (4.2) | 206 (5.3) | 234 (6.1) |
Triglycerides, mg/dL (mmol/L) | <150 (<1.7) | 638 (7.2) | 130 (1.5) | 62 (0.7) | 77 (0.9) | 93 (1.0) |
LDL, mg/dL (mmol/L) | <130 (<3.4) | — | 111 (2.9) | 86 (2.2) | 106 (2.7) | 170 (4.4) |
HDL, mg/dL (mmol/L) | >40 (>1.0) | 31 (0.8) | 41 (1.1) | 64 (1.7) | 83 (2.2) | 43 (1.1) |
FSH, IU/L | 3.5–12.5 | |||||
25.8–134.8c | 5.9 | 7.1 | 7.7 | 65.5 | 51.5 | |
LH, IU/L | 2.4–12.6 | 3.9 | 39.3 | 8.1 | 28.7 | 22.5 |
Testosterone, ng/dL (nmol/L) | 20–49 y: ≤48 (1.7) >50 y: ≤41 (1.4) | 32 (1.1)b | 101 (3.5) | 24 (0.8) | — | 46 (1.6) |
Androstenedione, ng/mL (nmol/L) | <2.2 (7.7) | — | 3.4 (11.9) | — | — | 0.75 (2.6) |
. | Reference Values . | Patient 1A . | Patient 1B . | Patient 3A . | Patient 3B . | Patient 4Ea . |
---|---|---|---|---|---|---|
Glucose, mg/dL (nmol/L) | 70–99 (3.9–5.5) | 173 (9.6) | 112 (6.2) | 85 (4.7) | 103 (5.7) | 124 (6.9) |
HbA1c, % | 4.1–6.0 | 9.5 | 6.5 | — | 5.9 | 8.4 |
Insulin, μU/mL | 2.6–24.9 | — | 51.6 | — | 13.6 | 21.1 |
Total cholesterol, mg/dL (mmol/L) | <190 (<4.9) | 192 (5.0) | 177 (4.6) | 162 (4.2) | 206 (5.3) | 234 (6.1) |
Triglycerides, mg/dL (mmol/L) | <150 (<1.7) | 638 (7.2) | 130 (1.5) | 62 (0.7) | 77 (0.9) | 93 (1.0) |
LDL, mg/dL (mmol/L) | <130 (<3.4) | — | 111 (2.9) | 86 (2.2) | 106 (2.7) | 170 (4.4) |
HDL, mg/dL (mmol/L) | >40 (>1.0) | 31 (0.8) | 41 (1.1) | 64 (1.7) | 83 (2.2) | 43 (1.1) |
FSH, IU/L | 3.5–12.5 | |||||
25.8–134.8c | 5.9 | 7.1 | 7.7 | 65.5 | 51.5 | |
LH, IU/L | 2.4–12.6 | 3.9 | 39.3 | 8.1 | 28.7 | 22.5 |
Testosterone, ng/dL (nmol/L) | 20–49 y: ≤48 (1.7) >50 y: ≤41 (1.4) | 32 (1.1)b | 101 (3.5) | 24 (0.8) | — | 46 (1.6) |
Androstenedione, ng/mL (nmol/L) | <2.2 (7.7) | — | 3.4 (11.9) | — | — | 0.75 (2.6) |
. | Reference Values . | Patient 1A . | Patient 1B . | Patient 3A . | Patient 3B . | Patient 4Ea . |
---|---|---|---|---|---|---|
Glucose, mg/dL (nmol/L) | 70–99 (3.9–5.5) | 173 (9.6) | 112 (6.2) | 85 (4.7) | 103 (5.7) | 124 (6.9) |
HbA1c, % | 4.1–6.0 | 9.5 | 6.5 | — | 5.9 | 8.4 |
Insulin, μU/mL | 2.6–24.9 | — | 51.6 | — | 13.6 | 21.1 |
Total cholesterol, mg/dL (mmol/L) | <190 (<4.9) | 192 (5.0) | 177 (4.6) | 162 (4.2) | 206 (5.3) | 234 (6.1) |
Triglycerides, mg/dL (mmol/L) | <150 (<1.7) | 638 (7.2) | 130 (1.5) | 62 (0.7) | 77 (0.9) | 93 (1.0) |
LDL, mg/dL (mmol/L) | <130 (<3.4) | — | 111 (2.9) | 86 (2.2) | 106 (2.7) | 170 (4.4) |
HDL, mg/dL (mmol/L) | >40 (>1.0) | 31 (0.8) | 41 (1.1) | 64 (1.7) | 83 (2.2) | 43 (1.1) |
FSH, IU/L | 3.5–12.5 | |||||
25.8–134.8c | 5.9 | 7.1 | 7.7 | 65.5 | 51.5 | |
LH, IU/L | 2.4–12.6 | 3.9 | 39.3 | 8.1 | 28.7 | 22.5 |
Testosterone, ng/dL (nmol/L) | 20–49 y: ≤48 (1.7) >50 y: ≤41 (1.4) | 32 (1.1)b | 101 (3.5) | 24 (0.8) | — | 46 (1.6) |
Androstenedione, ng/mL (nmol/L) | <2.2 (7.7) | — | 3.4 (11.9) | — | — | 0.75 (2.6) |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.